- Home
- CVKD vs DRIO Comparison
CVKD vs DRIO Comparison
Compare CVKD & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- DRIO
- Stock Information
- Founded
- CVKD 2022
- DRIO 2011
- Country
- CVKD United States
- DRIO United States
- Employees
- CVKD N/A
- DRIO N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- DRIO Medical/Dental Instruments
- Sector
- CVKD Health Care
- DRIO Health Care
- Exchange
- CVKD Nasdaq
- DRIO Nasdaq
- Market Cap
- CVKD 29.5M
- DRIO 30.5M
- IPO Year
- CVKD 2023
- DRIO N/A
- Fundamental
- Price
- CVKD $12.90
- DRIO $0.72
- Analyst Decision
- CVKD Strong Buy
- DRIO Strong Buy
- Analyst Count
- CVKD 1
- DRIO 2
- Target Price
- CVKD $32.00
- DRIO $2.50
- AVG Volume (30 Days)
- CVKD 34.8K
- DRIO 129.3K
- Earning Date
- CVKD 08-06-2025
- DRIO 08-07-2025
- Dividend Yield
- CVKD N/A
- DRIO N/A
- EPS Growth
- CVKD N/A
- DRIO N/A
- EPS
- CVKD N/A
- DRIO N/A
- Revenue
- CVKD N/A
- DRIO $28,034,000.00
- Revenue This Year
- CVKD N/A
- DRIO $13.66
- Revenue Next Year
- CVKD N/A
- DRIO $24.50
- P/E Ratio
- CVKD N/A
- DRIO N/A
- Revenue Growth
- CVKD N/A
- DRIO 47.20
- 52 Week Low
- CVKD $5.70
- DRIO $0.50
- 52 Week High
- CVKD $22.90
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- CVKD 49.22
- DRIO 50.61
- Support Level
- CVKD $11.00
- DRIO $0.67
- Resistance Level
- CVKD $13.56
- DRIO $0.72
- Average True Range (ATR)
- CVKD 1.13
- DRIO 0.03
- MACD
- CVKD 0.23
- DRIO 0.00
- Stochastic Oscillator
- CVKD 78.32
- DRIO 48.31
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.